nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—SHBG—gestational diabetes	0.351	0.383	CbGaD
Danazol—AR—gestational diabetes	0.308	0.336	CbGaD
Danazol—CYP19A1—gestational diabetes	0.258	0.281	CbGaD
Danazol—CCL2—tunica intima—gestational diabetes	0.0191	0.37	CbGeAlD
Danazol—CCL2—islet of Langerhans—gestational diabetes	0.00315	0.0609	CbGeAlD
Danazol—CCL2—embryo—gestational diabetes	0.00304	0.0589	CbGeAlD
Danazol—CCL2—uterus—gestational diabetes	0.00205	0.0397	CbGeAlD
Danazol—CCL2—adipose tissue—gestational diabetes	0.00201	0.0388	CbGeAlD
Danazol—GNRHR—head—gestational diabetes	0.00197	0.0382	CbGeAlD
Danazol—CCL2—vagina—gestational diabetes	0.00167	0.0323	CbGeAlD
Danazol—CCL2—head—gestational diabetes	0.00154	0.0298	CbGeAlD
Danazol—SHBG—Nongenotropic Androgen signaling—AR—gestational diabetes	0.00143	0.124	CbGpPWpGaD
Danazol—AR—Nongenotropic Androgen signaling—SHBG—gestational diabetes	0.00136	0.118	CbGpPWpGaD
Danazol—ESR1—embryo—gestational diabetes	0.00125	0.0242	CbGeAlD
Danazol—SHBG—uterus—gestational diabetes	0.0012	0.0232	CbGeAlD
Danazol—SHBG—adipose tissue—gestational diabetes	0.00117	0.0227	CbGeAlD
Danazol—Jaundice cholestatic—Glyburide—gestational diabetes	0.0011	0.0929	CcSEcCtD
Danazol—PGR—uterus—gestational diabetes	0.00108	0.0209	CbGeAlD
Danazol—PGR—adipose tissue—gestational diabetes	0.00105	0.0204	CbGeAlD
Danazol—SHBG—vagina—gestational diabetes	0.000973	0.0188	CbGeAlD
Danazol—CYP19A1—uterus—gestational diabetes	0.00097	0.0188	CbGeAlD
Danazol—CYP19A1—adipose tissue—gestational diabetes	0.000949	0.0184	CbGeAlD
Danazol—Stanozolol—AR—gestational diabetes	0.000948	0.118	CrCbGaD
Danazol—PGR—vagina—gestational diabetes	0.000877	0.017	CbGeAlD
Danazol—AR—uterus—gestational diabetes	0.000859	0.0166	CbGeAlD
Danazol—Oxandrolone—AR—gestational diabetes	0.000854	0.107	CrCbGaD
Danazol—ESR1—uterus—gestational diabetes	0.000843	0.0163	CbGeAlD
Danazol—AR—adipose tissue—gestational diabetes	0.00084	0.0163	CbGeAlD
Danazol—ESR1—adipose tissue—gestational diabetes	0.000825	0.016	CbGeAlD
Danazol—PGR—head—gestational diabetes	0.00081	0.0157	CbGeAlD
Danazol—Hepatic function abnormal—Glyburide—gestational diabetes	0.000804	0.0678	CcSEcCtD
Danazol—Visual disturbance—Glyburide—gestational diabetes	0.000741	0.0625	CcSEcCtD
Danazol—CYP19A1—head—gestational diabetes	0.000729	0.0141	CbGeAlD
Danazol—AR—vagina—gestational diabetes	0.000698	0.0135	CbGeAlD
Danazol—ESR1—vagina—gestational diabetes	0.000686	0.0133	CbGeAlD
Danazol—Desogestrel—SHBG—gestational diabetes	0.000671	0.0838	CrCbGaD
Danazol—AR—head—gestational diabetes	0.000645	0.0125	CbGeAlD
Danazol—ESR1—head—gestational diabetes	0.000633	0.0123	CbGeAlD
Danazol—Eosinophilia—Glyburide—gestational diabetes	0.000601	0.0507	CcSEcCtD
Danazol—Pancreatitis—Glyburide—gestational diabetes	0.000595	0.0502	CcSEcCtD
Danazol—PGR—Ovarian Infertility Genes—CYP19A1—gestational diabetes	0.000582	0.0503	CbGpPWpGaD
Danazol—Photosensitivity reaction—Glyburide—gestational diabetes	0.000554	0.0468	CcSEcCtD
Danazol—Etonogestrel—SHBG—gestational diabetes	0.000543	0.0678	CrCbGaD
Danazol—Testolactone—CYP19A1—gestational diabetes	0.000533	0.0667	CrCbGaD
Danazol—Jaundice—Glyburide—gestational diabetes	0.000528	0.0445	CcSEcCtD
Danazol—PGR—Nuclear Receptors—AR—gestational diabetes	0.000494	0.0427	CbGpPWpGaD
Danazol—Visual impairment—Glyburide—gestational diabetes	0.000468	0.0395	CcSEcCtD
Danazol—Alopecia—Glyburide—gestational diabetes	0.000429	0.0362	CcSEcCtD
Danazol—Vision blurred—Glyburide—gestational diabetes	0.000399	0.0336	CcSEcCtD
Danazol—Tremor—Glyburide—gestational diabetes	0.000396	0.0334	CcSEcCtD
Danazol—PGR—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00039	0.0337	CbGpPWpGaD
Danazol—Levonorgestrel—SHBG—gestational diabetes	0.000384	0.048	CrCbGaD
Danazol—Leukopenia—Glyburide—gestational diabetes	0.000379	0.032	CcSEcCtD
Danazol—Convulsion—Glyburide—gestational diabetes	0.000367	0.0309	CcSEcCtD
Danazol—Fluoxymesterone—SHBG—gestational diabetes	0.000366	0.0457	CrCbGaD
Danazol—Arthralgia—Glyburide—gestational diabetes	0.00036	0.0304	CcSEcCtD
Danazol—Testosterone Propionate—AR—gestational diabetes	0.000346	0.0433	CrCbGaD
Danazol—Oedema—Glyburide—gestational diabetes	0.000345	0.0291	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—LEPR—gestational diabetes	0.000344	0.0298	CbGpPWpGaD
Danazol—Shock—Glyburide—gestational diabetes	0.00034	0.0287	CcSEcCtD
Danazol—Thrombocytopenia—Glyburide—gestational diabetes	0.000338	0.0285	CcSEcCtD
Danazol—Levonorgestrel—AR—gestational diabetes	0.000337	0.0421	CrCbGaD
Danazol—Hyperhidrosis—Glyburide—gestational diabetes	0.000334	0.0282	CcSEcCtD
Danazol—Ethinyl Estradiol—SHBG—gestational diabetes	0.000324	0.0405	CrCbGaD
Danazol—Fluoxymesterone—AR—gestational diabetes	0.000321	0.0401	CrCbGaD
Danazol—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000315	0.0265	CcSEcCtD
Danazol—Norethindrone—SHBG—gestational diabetes	0.000311	0.0389	CrCbGaD
Danazol—Paraesthesia—Glyburide—gestational diabetes	0.00031	0.0262	CcSEcCtD
Danazol—Dyspepsia—Glyburide—gestational diabetes	0.000304	0.0256	CcSEcCtD
Danazol—Methyltestosterone—SHBG—gestational diabetes	0.000296	0.0369	CrCbGaD
Danazol—CCL2—IL23-mediated signaling events—TNF—gestational diabetes	0.000291	0.0252	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptors—AR—gestational diabetes	0.00029	0.0251	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—GGCT—gestational diabetes	0.000286	0.0247	CbGpPWpGaD
Danazol—Levonorgestrel—CYP19A1—gestational diabetes	0.000282	0.0352	CrCbGaD
Danazol—Urticaria—Glyburide—gestational diabetes	0.000274	0.0231	CcSEcCtD
Danazol—CCL2—TWEAK Signaling Pathway—TNF—gestational diabetes	0.000263	0.0227	CbGpPWpGaD
Danazol—Methyltestosterone—AR—gestational diabetes	0.000259	0.0324	CrCbGaD
Danazol—ESR1—FOXA1 transcription factor network—AR—gestational diabetes	0.000258	0.0223	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000256	0.0222	CbGpPWpGaD
Danazol—PGR—Cellular roles of Anthrax toxin—TNF—gestational diabetes	0.000254	0.022	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—LEP—gestational diabetes	0.000249	0.0215	CbGpPWpGaD
Danazol—Asthenia—Glyburide—gestational diabetes	0.000248	0.0209	CcSEcCtD
Danazol—Pruritus—Glyburide—gestational diabetes	0.000244	0.0206	CcSEcCtD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000234	0.0203	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.000229	0.0198	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000225	0.0195	CbGpPWpGaD
Danazol—Hydrocortisone—SHBG—gestational diabetes	0.000223	0.0278	CrCbGaD
Danazol—Vomiting—Glyburide—gestational diabetes	0.00022	0.0185	CcSEcCtD
Danazol—Rash—Glyburide—gestational diabetes	0.000218	0.0184	CcSEcCtD
Danazol—Dermatitis—Glyburide—gestational diabetes	0.000218	0.0184	CcSEcCtD
Danazol—Methyltestosterone—CYP19A1—gestational diabetes	0.000217	0.0271	CrCbGaD
Danazol—Headache—Glyburide—gestational diabetes	0.000216	0.0183	CcSEcCtD
Danazol—Nausea—Glyburide—gestational diabetes	0.000205	0.0173	CcSEcCtD
Danazol—CCL2—GPCR ligand binding—MTNR1B—gestational diabetes	0.000195	0.0169	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TNF—gestational diabetes	0.000183	0.0158	CbGpPWpGaD
Danazol—Progesterone—SHBG—gestational diabetes	0.000181	0.0227	CrCbGaD
Danazol—GNRHR—GPCR ligand binding—MTNR1B—gestational diabetes	0.000179	0.0154	CbGpPWpGaD
Danazol—Testosterone—SHBG—gestational diabetes	0.000171	0.0214	CrCbGaD
Danazol—AR—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000171	0.0148	CbGpPWpGaD
Danazol—Progesterone—AR—gestational diabetes	0.000159	0.0199	CrCbGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—AR—gestational diabetes	0.000158	0.0137	CbGpPWpGaD
Danazol—Testosterone—AR—gestational diabetes	0.00015	0.0188	CrCbGaD
Danazol—CCL2—Selenium Micronutrient Network—TNF—gestational diabetes	0.000145	0.0126	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.00014	0.0121	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000128	0.0111	CbGpPWpGaD
Danazol—Testosterone—CYP19A1—gestational diabetes	0.000126	0.0157	CrCbGaD
Danazol—ESR1—Leptin signaling pathway—LEP—gestational diabetes	0.000121	0.0105	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TNF—gestational diabetes	0.000115	0.00994	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000107	0.00928	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000101	0.00873	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MTNR1B—gestational diabetes	0.0001	0.00866	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	9.87e-05	0.00854	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—AR—gestational diabetes	9.61e-05	0.00831	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MTNR1B—gestational diabetes	9.16e-05	0.00792	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—FGF2—gestational diabetes	8.89e-05	0.00769	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GGCT—gestational diabetes	8.34e-05	0.00721	CbGpPWpGaD
Danazol—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	8.33e-05	0.0072	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	8.27e-05	0.00715	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	7.96e-05	0.00688	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LEPR—gestational diabetes	7.49e-05	0.00648	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LEPR—gestational diabetes	6.85e-05	0.00592	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—AR—gestational diabetes	6.74e-05	0.00583	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	6.74e-05	0.00583	CbGpPWpGaD
Danazol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	6.65e-05	0.00575	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—LEP—gestational diabetes	6.1e-05	0.00528	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MTNR1B—gestational diabetes	5.92e-05	0.00512	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RBP4—gestational diabetes	5.77e-05	0.00499	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	5.64e-05	0.00488	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	5.46e-05	0.00472	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MTNR1B—gestational diabetes	5.41e-05	0.00468	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RBP4—gestational diabetes	5.28e-05	0.00456	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—FGF2—gestational diabetes	5.22e-05	0.00451	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GGCT—gestational diabetes	4.88e-05	0.00422	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	4.35e-05	0.00376	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEPR—gestational diabetes	4.32e-05	0.00373	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GLS2—gestational diabetes	4.27e-05	0.00369	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—gestational diabetes	4.04e-05	0.0035	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—AR—gestational diabetes	3.95e-05	0.00342	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	3.44e-05	0.00297	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MTNR1B—gestational diabetes	3.41e-05	0.00295	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RBP4—gestational diabetes	3.33e-05	0.00288	CbGpPWpGaD
Danazol—PGR—Gene Expression—AR—gestational diabetes	3.24e-05	0.00281	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	2.9e-05	0.00251	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	2.86e-05	0.00247	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	2.65e-05	0.00229	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LEP—gestational diabetes	2.63e-05	0.00227	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEPR—gestational diabetes	2.53e-05	0.00219	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LEP—gestational diabetes	2.41e-05	0.00208	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NAMPT—gestational diabetes	2.34e-05	0.00202	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GCK—gestational diabetes	2.32e-05	0.00201	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MTNR1B—gestational diabetes	2e-05	0.00173	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FGF2—gestational diabetes	2e-05	0.00173	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RBP4—gestational diabetes	1.95e-05	0.00169	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AR—gestational diabetes	1.9e-05	0.00165	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FGF2—gestational diabetes	1.83e-05	0.00158	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEP—gestational diabetes	1.52e-05	0.00131	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GGCT—gestational diabetes	1.43e-05	0.00123	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GLS2—gestational diabetes	1.25e-05	0.00108	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGF2—gestational diabetes	1.15e-05	0.000996	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEP—gestational diabetes	8.9e-06	0.00077	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NAMPT—gestational diabetes	6.83e-06	0.00059	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCK—gestational diabetes	6.78e-06	0.000587	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF2—gestational diabetes	6.76e-06	0.000585	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP19A1—gestational diabetes	4.96e-06	0.000429	CbGpPWpGaD
